About Angita Pharmaceuticals

Angita is a biotechnology company specialised in the discovery and development of novel treatment concepts and identification of small molecules for use in the treatment of unmet clinical needs. Our target indications are diseases of the CNS, and other indications in which the CNS plays a key modulator role.

Angita focuses on early stage drug discovery and development projects via collaboration with academic groups on the elaboration of project concepts and other drug discovery and development companies to optimise the progress of our pipeline projects.

Affiliates & Sponsors